Optimal glucocorticoid dose and the effects on mortality, length of stay, and readmission rates in patients diagnosed with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Asim Kichloo, Michael Aljadah, Navya Vipparla, Farah Wani
DOI: 10.1136/jim-2019-001105 Published 26 November 2019
Asim Kichloo
1
Department of Internal Medicine, Central Michigan University, Saginaw, Michigan, USA
Michael Aljadah
1
Department of Internal Medicine, Central Michigan University, Saginaw, Michigan, USA
2
Internal Medicine, Central Michigan University, Saginaw, Michigan, USA
Navya Vipparla
1
Department of Internal Medicine, Central Michigan University, Saginaw, Michigan, USA
2
Internal Medicine, Central Michigan University, Saginaw, Michigan, USA
Farah Wani
1
Department of Internal Medicine, Central Michigan University, Saginaw, Michigan, USA
3
Department of Internal Medicine, St Mary’s Hospital, Saginaw, Michigan, USA
Submit a Response to This Article
No eLetters have been published for this article.
Optimal glucocorticoid dose and the effects on mortality, length of stay, and readmission rates in patients diagnosed with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Asim Kichloo, Michael Aljadah, Navya Vipparla, Farah Wani
Journal of Investigative Medicine Dec 2019, 67 (8) 1161-1164; DOI: 10.1136/jim-2019-001105
Optimal glucocorticoid dose and the effects on mortality, length of stay, and readmission rates in patients diagnosed with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Asim Kichloo, Michael Aljadah, Navya Vipparla, Farah Wani
Journal of Investigative Medicine Dec 2019, 67 (8) 1161-1164; DOI: 10.1136/jim-2019-001105
Optimal glucocorticoid dose and the effects on mortality, length of stay, and readmission rates in patients diagnosed with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Asim Kichloo, Michael Aljadah, Navya Vipparla, Farah Wani
Journal of Investigative Medicine Dec 2019, 67 (8) 1161-1164; DOI: 10.1136/jim-2019-001105